View Post Efficacy, Safety, and Tolerability of Etravirine With and Without Darunavir/Ritonavir or Raltegravir in Treatment-Experienced Patients: Analysis of the Etravirine Early Access Program in the United States. Journal of Acquired Immune Deficiency Syndrome, 53(5): 614-618. In by AHFApril 1, 2010
View Post A Randomized Trial Assessing the Impact of Phenotypic Resistance Testing on Antiretroviral Therapy. AIDS, 16(4): 579-588. In by AHFOctober 1, 2001
